
Gajuwaka Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading medicines, food products, and chemical compounds.
Pharmaceutical company manufacturing and trading medicines, food products, and chemical compounds.
Gajuwaka Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 January 2002 and has a history of 23 years and one month. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.88 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹8.50 M, as per Ministry of Corporate Affairs (MCA) records.
Papa Vegi, Narasimharaju Datlavenkata, Venkata Kethineedi, and Three other members serve as directors at the Company.
Visakhapatnam, Andhra Pradesh, India
+91-XXXXXXXXXX
U24239AP2002PTC038342
038342
Private Limited Indian Non-Government Company
10 Jan 2002
30 Sep 2023
31 Mar 2023
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Papa Vegi ![]() | Managing Director | 10-Jan-2002 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narasimharaju Datlavenkata ![]() | Director | 14-Mar-2014 | Current |
Venkata Kethineedi ![]() | Director | 14-Mar-2014 | Current |
Surya Kandregula ![]() | Director | 14-Mar-2014 | Current |
Narayana Kandregula ![]() | Director | 19-Mar-2018 | Current |
Adi Konathala ![]() | Director | 19-Mar-2018 | Current |
Gajuwaka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.17% decrease. The company also saw a slight decrease in profitability, with a 0.77% decrease in profit. The company's net worth Soared by an impressive increase of 118.65%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Gajuwaka Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Papa Vegi, Narasimharaju Datlavenkata and 1 more are mutual person
Papa Vegi and Narasimharaju Datlavenkata are mutual person
Papa Vegi, Narasimharaju Datlavenkata and 1 more are mutual person
Papa Vegi, Narasimharaju Datlavenkata and 2 more are mutual person
Papa Vegi and Narasimharaju Datlavenkata are mutual person
Narasimharaju Datlavenkata is a mutual person
₹4.00 M
₹8.50 M
Date | Lender | Amount | Status |
---|---|---|---|
30 May 2014 | The Karur Vysya Bank Limited | ₹4.00 M | Open |
30 Nov 2006 | Indian Overseas Bank | ₹3.50 M | Satisfied |
22 Sep 2005 | State Bank Of India | ₹2.50 M | Satisfied |
23 Mar 2004 | Indian Overseas Bank | ₹2.50 M | Satisfied |
Unlock and access historical data on people associated with Gajuwaka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gajuwaka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gajuwaka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gajuwaka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Gajuwaka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
Narayana Murthy Kandregula was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 6 years 11 months .
Adi Ganeswararao Konathala was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 6 years 11 months .
A charge registered on 23 Mar 2004 via Charge ID 90119267 with Indian Overseas Bank was fully satisfied on 02 Jan 2018.
A charge registered on 30 Nov 2006 via Charge ID 10032987 with Indian Overseas Bank was fully satisfied on 08 Dec 2017.
Gajuwaka Pharmaceuticals Private Limited was incorporated on 10 Jan 2002.
The authorized share capital of Gajuwaka Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.88 M.
Currently 6 directors are associated with Gajuwaka Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gajuwaka Pharmaceuticals Private Limited is 9-7-211/4 Shankar Nagar 3Rd Lane Beside Lakshmikanth Theatre, Gajuwaka India, Visakhapatnam, Andhra Pradesh, 530026.
The corporate identification number (CIN) of Gajuwaka Pharmaceuticals Private Limited is U24239AP2002PTC038342 and the company number is 038342 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Gajuwaka Pharmaceuticals Private Limited has fallen by -13.17%.
The financial reports for the fiscal year 2023 indicates that The net worth of Gajuwaka Pharmaceuticals Private Limited has experienced an upsurge of 118.65%.
As per the financial statements for fiscal Year 2023, The total open charges for Gajuwaka Pharmaceuticals Private Limited amount to ₹ 4.00 M.
The most recent Balance Sheet for Gajuwaka Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
AS
BS
PS
JK